October 26, 2011

Solasia Announces Initiation of Darinaparsin Injection(SP-02) Phase 1 Study (PDF)

March 8, 2011

ZIOPHARM and Solasia Pharma Announce License and Collaboration Agreement for Darinaparsin in Asia (PDF)

March 3, 2010

Solasia Pharma and Kyowa Hakko Kirin enter into a License Agreement for SP-01(Sancuso®)in Asia (PDF)

October 30, 2009

Completion of Phase I clinical trial of Sancuso® in Japanese volunteers (PDF)

June 1, 2009

Sancuso® clinical trial application filed in China (PDF)

April 1, 2009

Announcement of Office Move (PDF)

March 9, 2009

Clinical Development of Solasia’s first drug initiated in Japan – Clinical trials also planned for China (PDF)

October 1, 2008

JapanBridge changes name to Solasia Pharma K.K. to reflect focus on asian strategy (PDF)

May 23, 2008

JapanBridge (Current Solasia Pharma K.K.) and prostrakan partner to develop sancuso® in japan, China & parts of south east asia (PDF)

September 22, 2007

JapanBridge, inc.(Current Solasia Pharma K.K.), signs alliance with Kyowa Hakko Kogyo co., ltd.; closes $6.5 million series a-2 preferred financing (PDF)

December 3, 2006

Itochu Corporation and MPM Capital fund JapanBridge(Current Solasia Pharma k.k.), specialty pharmaceutical company for asian market (PDF)